Medexus Pharmaceuticals
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1 Pl Du Commerce Ste 225, Verdun, Quebec...Phone Number
(514) 762-2626Website
www.medexus.comRevenue
$115.7 MillionStock Symbol
MEDXFIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Medexus Pharmaceuticals
Medexus Pharmaceuticals is a leading innovative and rare disease, pharmaceutical company with a strong North American commercial platform. Medexus Pharmaceuticals is headquartered in Ontario, Canada.Explore more
Medexus Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Medexus Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Medexus Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Medexus Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Medexus Pharmaceuticals has new funding data
Check if Medexus Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Medexus Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Medexus Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Medexus Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Medexus Pharmaceuticals
Recommended Actions
Find VP level buyers at Medexus Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Medexus Pharmaceuticals
Compare insights from companies similar to Medexus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Medexus Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Medexus Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Medexus Pharmaceuticals.
Medexus Pharmaceuticals financials insights
Gather financial insights about Medexus Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Debt
$25M
Medexus Pharmaceuticals Tech Stack
A closer look at the technologies used by Medexus Pharmaceuticals
See more technologies
Most Recent Scoops
Hiring Plans
Medexus Pharmaceuticals is hiring in Information Technology for the first time in 12 months. Areas of expertise include: HubSpot API, Information Privacy, Data Integrity, Limited User Administration, Dashboard, Software Documentation, and Release Management.
Hiring Plans
Earnings
Medexus Pharmaceuticals has reported product-level net revenue from GRAFAPEX of $3.4 million for fiscal Q4 2026, exceeding the $2.7 million of GRAFAPEX personnel and infrastructure investments in the same period, contributing to a $2.0 million increase in adjusted EBITDA for the quarter.
Earnings, Business Finance, Finance
Earnings
Medexus Pharmaceuticals has reported cash on hand of $6.5 million as of 31 March 2026, compared to $24.0 million as of 31 March 2025, with the decrease primarily attributable to the payment in full of a $15.0 million regulatory milestone under the GRAFAPEX agreement during fiscal year 2026.
Accounting, Financial Reporting, Business Finance, Finance, Financial Transactions
Project
Medexus Pharmaceuticals has signed agreements for the exclusive Canadian rights to commercialize UM171 cell therapy, a proprietary advanced clinical-stage investigational drug that recently received conditional marketing authorization in Europe from the European Commission as Zemcelpro.
Pharmaceuticals
Earnings
Spending/Investment, Research & Development
Medexus Pharmaceuticals News & Media
Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada
- Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission - Exclusive licensing and supply agreements have been granted to Medexus for the Canadian commercialization rights for Zemcelpro® (if...Zemcelpro® (UM171 Cell Therapy) licensing and supply agreements announced for Canada
- Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission - Exclusive licensing and supply agreements have been granted to Medexus for the Canadian commercialization rights for Zemcelpro® (if...Medexus Pharmaceuticals Inc. (MDP:CA) Q3 2026 Earnings Call Transcript
Medexus Pharmaceuticals Inc. (MDP:CA) Q3 2026 Earnings Call February 12, 2026 8:00 AM ESTCompany ParticipantsVictoria RutherfordKenneth d'Entremont - CEO...Medexus Pharmaceuticals Q3 Earnings Call Highlights
Medexus Pharmaceuticals (TSE:MDP) highlighted continued momentum for its U.S. launch of GRAFAPEX while reporting lower year-over-year revenue and earnings in its fiscal third quarter of 2026, management said on the company’s earnings call. Executives emphasized improving demand trends for GRAFAPEX f
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Medexus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Medexus Pharmaceuticals is a leading innovative and rare disease, pharmaceutical company with a strong North American commercial platform. Medexus Pharmaceuticals is headquartered in Ontario, Canada.... Read More
